BACKGROUND: It has been debated that the epidemic of melanoma is largely due to overdiagnosis, since increases in incidence were mainly among thin melanomas and mortality rates remained stable. Our objective was to examine this controversy in The Netherlands. PATIENTS AND METHODS: Information on newly diagnosed melanoma patients was obtained from The Netherlands Cancer Registry. European Standardized Rates and estimated annual percentage change were calculated for the period 1989-2008. Cohort-based, period-based and multivariate survival analyses were carried out. RESULTS: The incidence rate of melanoma increased with 4.1% (95% confidence interval 3.6-4.5) annually. Incidence rates of both thin melanomas (≤ 1 mm) and thick melanomas (> 4 mm) increased since 1989. Mortality rates increased mainly in older patients (> 65 years). Ten-year relative survival of males improved significantly from 70% in 1989-1993 to 77% in 2004-2008 (P < 0.001) and for females the 10-year relative survival increased from 85% to 88% (P < 0.01). Recently diagnosed patients had a better prognosis even after adjusting for all known prognostic factors. CONCLUSION: Since incidence of melanomas among all Breslow thickness categories increased as well as the mortality rates, the melanoma epidemic in The Netherlands seems to be real and not only due to overdiagnosis.
BACKGROUND: It has been debated that the epidemic of melanoma is largely due to overdiagnosis, since increases in incidence were mainly among thin melanomas and mortality rates remained stable. Our objective was to examine this controversy in The Netherlands. PATIENTS AND METHODS: Information on newly diagnosed melanomapatients was obtained from The Netherlands Cancer Registry. European Standardized Rates and estimated annual percentage change were calculated for the period 1989-2008. Cohort-based, period-based and multivariate survival analyses were carried out. RESULTS: The incidence rate of melanoma increased with 4.1% (95% confidence interval 3.6-4.5) annually. Incidence rates of both thin melanomas (≤ 1 mm) and thick melanomas (> 4 mm) increased since 1989. Mortality rates increased mainly in older patients (> 65 years). Ten-year relative survival of males improved significantly from 70% in 1989-1993 to 77% in 2004-2008 (P < 0.001) and for females the 10-year relative survival increased from 85% to 88% (P < 0.01). Recently diagnosed patients had a better prognosis even after adjusting for all known prognostic factors. CONCLUSION: Since incidence of melanomas among all Breslow thickness categories increased as well as the mortality rates, the melanoma epidemic in The Netherlands seems to be real and not only due to overdiagnosis.
Authors: Susana Puig; Joaquim Marcoval; Cristina Paradelo; Antoni Azon; Ramon Bartralot; Susana Bel; Xavier Bigata; Aram Boada; Antoni Campoy; Cristina Carrera; Neus Curco; Joan Dalmau; Carlos Ferrándiz; Josep R Ferreres; Manel Formigon; Fernando Gallardo; Alberto Gonzalez; Miquel Just; Enric Llistosella; Rosa M Marti; M Elena Nogues; Ramon Pedragosa; Josep A Pujol; Rodrigo Roldán-Marín; Mireia Sabat; Montserrat Salleras; Juan A Smandia; Pedro Zaballos; Estel Plana; Josep Malvehy Journal: Acta Derm Venereol Date: 2015-04 Impact factor: 4.437
Authors: J Rubió-Casadevall; M Puig-Vives; M Puigdemont; L Vilardell; A Carbó-Bagué; R Marcos-Gragera; N Vilar-Coromina Journal: Clin Transl Oncol Date: 2018-06-05 Impact factor: 3.405
Authors: M J Rutherford; L Ironmonger; N Ormiston-Smith; G A Abel; D C Greenberg; G Lyratzopoulos; P C Lambert Journal: Br J Cancer Date: 2015-03-31 Impact factor: 7.640
Authors: Eline Noels; Loes Hollestein; Kees Luijkx; Marieke Louwman; Carin de Uyl-de Groot; Renate van den Bos; Astrid van der Veldt; Dirk Grünhagen; Marlies Wakkee Journal: Acta Derm Venereol Date: 2020-05-28 Impact factor: 3.875
Authors: Cecile J L Koelink; Boudewijn J Kollen; Feikje Groenhof; Klaas van der Meer; Wouter K van der Heide Journal: BMC Fam Pract Date: 2014-02-12 Impact factor: 2.497
Authors: Samantha Damude; Josette E H M Hoekstra-Weebers; Anne Brecht Francken; Sylvia Ter Meulen; Esther Bastiaannet; Harald J Hoekstra Journal: Ann Surg Oncol Date: 2016-05-18 Impact factor: 5.344